{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:49:53Z","timestamp":1782380993566,"version":"3.54.5"},"reference-count":51,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018270","name":"Health Service Executive","doi-asserted-by":"crossref","award":["55838838"],"award-info":[{"award-number":["55838838"]}],"id":[{"id":"10.13039\/100018270","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,2,10]]},"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to develop and assess the feasibility and cost impact of an intervention involving a practice pharmacist embedded in general practice to improve prescribing safety, deprescribe where appropriate and reduce costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Four-doctor suburban general practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Inclusion criteria: patients receiving 10+ repeat drugs per month. Exclusion criteria: deceased, &lt;18 years of age, nursing home resident, no longer attending, late-stage life-limiting condition, unsuitable on clinical\/capacity grounds. 137 patients were eligible. 78 were recruited as participants, all of whom completed the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Pharmacist conducting holistic medication reviews in the study group over a 6-month period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary outcome measures<\/jats:title>\n                    <jats:p>Anonymised medication changes, cost, biochemical monitoring and clinical measurements data were collected. Cost analysis of having a pharmacist as part of the general practice team was calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 198 potentially inappropriate prescriptions (PIPs), and 163 opportunities for deprescribing were identified; 127 PIPs (64.1%) were actioned; 104 deprescribing opportunities were actioned (63.8%). The pharmacist identified 101 instances in which further investigations were warranted prior to prescription issue, of which 80 were actioned (79.2%). It was calculated that monthly savings of \u20ac1252 were made as a result of deprescribing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study has shown that the integration of pharmacists within general practice in Ireland is feasible and is an effective means of improving prescribing safety and implementing deprescribing through medication reviews. The combination of safety and cost concerns support taking a holistic approach to deprescribing with the patient. This study highlights the ease with which a pharmacist could integrate into the general practice setting in Ireland and points to how this could be sustainably funded.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-050261","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T10:45:34Z","timestamp":1653648334000},"page":"e050261","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting"],"prefix":"10.1136","volume":"12","author":[{"given":"Darach","family":"\u00d3 Ciardha","sequence":"first","affiliation":[{"name":"Institute of Population Health, Trinity College Dublin School of Medicine, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Blake","sequence":"additional","affiliation":[{"name":"Institute of Population Health, Trinity College Dublin School of Medicine, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4321-6368","authenticated-orcid":false,"given":"Dylan","family":"Creane","sequence":"additional","affiliation":[{"name":"Institute of Population Health, Trinity College Dublin School of Medicine, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael \u00d3","family":"Callaghan","sequence":"additional","affiliation":[{"name":"Institute of Population Health, Trinity College Dublin School of Medicine, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-7076","authenticated-orcid":false,"given":"Catherine","family":"Darker","sequence":"additional","affiliation":[{"name":"Institute of Population Health, Trinity College Dublin School of Medicine, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"2025120520014125000_12.5.e050261.1","unstructured":"World Health Organisation . The World Medicines Situation [Internet], 2004. Available: https:\/\/www.who.int\/medicines\/areas\/policy\/world_medicines_situation\/en\/"},{"key":"2025120520014125000_12.5.e050261.2","unstructured":"World Health Organisation . Medication safety in polypharmacy: technical report [Internet], 2019. Available: https:\/\/www.who.int\/publications\/i\/item\/medication-safety-in-polypharmacy-technical-report"},{"key":"2025120520014125000_12.5.e050261.3","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0621-2"},{"key":"2025120520014125000_12.5.e050261.4","unstructured":"National Institute for Health and Care Excellence (NICE) . Multimorbidity and polypharmacy [Internet], 2019. Available: https:\/\/www.nice.org.uk\/advice\/ktt18"},{"key":"2025120520014125000_12.5.e050261.5","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp11X556146"},{"key":"2025120520014125000_12.5.e050261.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61091-5"},{"key":"2025120520014125000_12.5.e050261.7","doi-asserted-by":"publisher","DOI":"10.1177\/2042098615615472"},{"key":"2025120520014125000_12.5.e050261.8","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_132_16"},{"key":"2025120520014125000_12.5.e050261.9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/jgs.16239","article-title":"Comparing potentially inappropriate prescribing tools and their association with patient outcomes","volume":"68","author":"Moriarty","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"2025120520014125000_12.5.e050261.10","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12161"},{"key":"2025120520014125000_12.5.e050261.11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5694\/mja14.01486","article-title":"First do no harm: a real need to deprescribe in older patients","volume":"202","author":"Kouladjian","year":"2015","journal-title":"Med J Aust"},{"key":"2025120520014125000_12.5.e050261.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-014-2924-8"},{"key":"2025120520014125000_12.5.e050261.13","unstructured":"Bruy\u00e8re Research Institute . What is deprescribing? [Internet], 2020. Available: https:\/\/deprescribing.org\/what-is-deprescribing\/"},{"key":"2025120520014125000_12.5.e050261.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.01916.x"},{"key":"2025120520014125000_12.5.e050261.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h176","article-title":"Managing patients with multimorbidity in primary care","volume":"350","author":"Wallace","year":"2015","journal-title":"BMJ"},{"key":"2025120520014125000_12.5.e050261.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-016-0552-6","article-title":"Identification of priorities for improvement of medication safety in primary care: a prioritize study","volume":"17","author":"Tudor Car","year":"2016","journal-title":"BMC Fam Pract"},{"key":"2025120520014125000_12.5.e050261.17","unstructured":"Oscar J , Karen C , Frank M , General Practice Pharmacist Study G . Pharmacists in general practice - a qualitative process evaluation of the General Practice Pharmacist (GPP) study 2020."},{"key":"2025120520014125000_12.5.e050261.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2013.08.006"},{"key":"2025120520014125000_12.5.e050261.19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.sapharm.2017.04.014","article-title":"The degree of integration of non-dispensing pharmacists in primary care practice and the impact on health outcomes: a systematic review","volume":"14","author":"Hazen","year":"2018","journal-title":"Res Social Adm Pharm"},{"key":"2025120520014125000_12.5.e050261.20","doi-asserted-by":"publisher","DOI":"10.2147\/iprp.s108047"},{"key":"2025120520014125000_12.5.e050261.21","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.7.1798"},{"key":"2025120520014125000_12.5.e050261.22","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.08.020306","article-title":"Chronic obstructive pulmonary disease: a disease of old age?","volume":"8","author":"Boudewijns","year":"2018","journal-title":"J Glob Health"},{"key":"2025120520014125000_12.5.e050261.23","unstructured":"Scottish Government Model of Care Polypharmacy Working Group . Polypharmacy guidance. 2nd edn. Scottish Government, 2015."},{"key":"2025120520014125000_12.5.e050261.24","doi-asserted-by":"crossref","unstructured":"Ciardha \u00d3 , Blake A , Creane D . Data from: can a practice pharmacist improve prescribing safety and reduce costs in polypharmacy patients? A pilot study of an intervention in an Irish general practice setting. Zenovo repository, 2021.","DOI":"10.1136\/bmjopen-2021-050261"},{"key":"2025120520014125000_12.5.e050261.25","unstructured":"Health Service Executive (HSE) . Reimbursable items - medicines and aids provided, 2020. Available: https:\/\/www.hse.ie\/eng\/staff\/pcrs\/items\/"},{"key":"2025120520014125000_12.5.e050261.26","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-012-9701-8"},{"key":"2025120520014125000_12.5.e050261.27","first-page":"17","article-title":"A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients","volume":"169","author":"Sellors","year":"2003","journal-title":"CMAJ"},{"key":"2025120520014125000_12.5.e050261.28","first-page":"83","article-title":"Community pharmacy medicines use review: current challenges","volume":"7","author":"Latif","year":"2017","journal-title":"Integr Pharm Res Pract"},{"key":"2025120520014125000_12.5.e050261.29","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afu145"},{"key":"2025120520014125000_12.5.e050261.30","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15767"},{"key":"2025120520014125000_12.5.e050261.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2005.00681.x"},{"key":"2025120520014125000_12.5.e050261.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008656"},{"key":"2025120520014125000_12.5.e050261.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03628.x"},{"key":"2025120520014125000_12.5.e050261.34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019003"},{"key":"2025120520014125000_12.5.e050261.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035087"},{"key":"2025120520014125000_12.5.e050261.36","first-page":"Cd004273","article-title":"Interventions for improving older patients' involvement in primary care episodes","volume":"2007","author":"Wetzels","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120520014125000_12.5.e050261.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2007.06.012"},{"key":"2025120520014125000_12.5.e050261.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010063"},{"key":"2025120520014125000_12.5.e050261.39","unstructured":"Agency for Healthcare Research and Quality . The CAHPS ambulatory care improvement guide: practical strategies for improving patient experience. Rockville, MD, 2020. https:\/\/www.ahrq.gov\/cahps\/quality-improvement\/improvement-guide\/improvement-guide.html"},{"key":"2025120520014125000_12.5.e050261.40","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-006-0021-3"},{"key":"2025120520014125000_12.5.e050261.41","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2011-000609"},{"key":"2025120520014125000_12.5.e050261.42","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-10-321"},{"key":"2025120520014125000_12.5.e050261.43","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the empower cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025120520014125000_12.5.e050261.44","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.4.424"},{"key":"2025120520014125000_12.5.e050261.45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40264-020-00918-3","article-title":"Prevalence and nature of medication errors and medication-related harm following discharge from hospital to community settings: a systematic review","volume":"43","author":"Alqenae","year":"2020","journal-title":"Drug Saf"},{"key":"2025120520014125000_12.5.e050261.46","unstructured":"World Health Organization (WHO) . Medication safety in transitions of care: technical report 2019."},{"key":"2025120520014125000_12.5.e050261.47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4079"},{"key":"2025120520014125000_12.5.e050261.48","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X710429"},{"key":"2025120520014125000_12.5.e050261.49","unstructured":"Christopher J . Working together to help patients make the most of medicines - Report of the Royal College of Nursing and Royal Pharmaceutical Society Joint Summit held on 2 December 2014;2014."},{"key":"2025120520014125000_12.5.e050261.50","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-177"},{"key":"2025120520014125000_12.5.e050261.51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1108\/JICA-04-2020-0019","article-title":"Appropriate polypharmacy: a barometer for integrated care","volume":"29","author":"Mair","year":"2020","journal-title":"J Integr Care"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-050261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:01:49Z","timestamp":1764993709000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-050261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,27]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1136\/bmjopen-2021-050261"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-050261","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}